Regulation of aPKC activity by Nup358 dependent SUMO modification.
Atypical PKC (aPKC) family members are involved in regulation of diverse cellular processes, including cell polarization. aPKCs are known to be activated by phosphorylation of specific threonine residues in the activation loop and turn motif. They can also be stimulated by interaction with Cdc42~GTP-Par6 complex. Here we report that PKCζ, a member of the aPKC family, is activated by SUMOylation. We show that aPKC is endogenously modified by SUMO1 and the nucleoporin Nup358 acts as its SUMO E3 ligase. Results from in vitro SUMOylation and kinase assays showed that the modification enhances the kinase activity of PKCζ by ~10-fold. By monitoring the phosphorylation of Lethal giant larvae (Lgl), a downstream target of aPKC, we confirmed these findings in vivo. Consistent with the function of Nup358 as a SUMO E3 ligase for aPKC, depletion of Nup358 attenuated the extent of SUMOylation and the activity of aPKC. Moreover, overexpression of the C-terminal fragment of Nup358 that possesses the E3 ligase activity enhanced SUMOylation of endogenous aPKC and its kinase activity. Collectively, our studies reveal a role for Nup358-dependent SUMOylation in the regulation of aPKC activity and provide a framework for understanding the role of Nup358 in cell polarity.
National Centre for Cell Science, S.P. Pune University Campus, Ganeshkhind, Pune 411007, India.
Santosh Kumar
SK
Yadav
National Centre for Cell Science, S.P. Pune University Campus, Ganeshkhind, Pune 411007, India.
Indrasen
I
Magre
National Centre for Cell Science, S.P. Pune University Campus, Ganeshkhind, Pune 411007, India.
Aditi
A
Singh
National Centre for Cell Science, S.P. Pune University Campus, Ganeshkhind, Pune 411007, India.
Deepak
D
Khuperkar
National Centre for Cell Science, S.P. Pune University Campus, Ganeshkhind, Pune 411007, India.
Jomon
J
Joseph
J Cell Biol. 2011 Aug 22;194(4):597-612
21859863
Curr Biol. 1998 Sep 24;8(19):1069-77
9768361
Cell. 2002 Jan 11;108(1):109-20
11792325
J Cell Biol. 2002 Jul 8;158(1):63-77
12105182
J Biochem. 2003 Jan;133(1):1-7
12761192
Exp Cell Res. 2013 Jun 10;319(10):1357-64
23535009
Annu Rev Biochem. 2004;73:355-82
15189146
Nat Cell Biol. 2000 Aug;2(8):540-7
10934475
J Biol Chem. 2015 Sep 25;290(39):23589-602
26251516
Cell. 2008 Apr 4;133(1):103-15
18394993
Mol Cell. 2005 Apr 1;18(1):1-12
15808504
Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71
21102611
J Cell Sci. 2009 Apr 15;122(Pt 8):1100-10
19299463
Nature. 2003 Mar 20;422(6929):326-30
12629552
FASEB J. 1995 May;9(8):576-96
7768349
Nat Rev Cancer. 2012 Dec;12 (12 ):877-86
23175122
Immunol Rev. 2012 Mar;246(1):154-67
22435553
Curr Biol. 2004 Apr 6;14(7):611-7
15062103
PLoS One. 2014 Feb 20;9(2):e88887
24586428
Trends Cell Biol. 2007 Aug;17(8):370-6
17768054
EMBO J. 1997 Sep 15;16(18):5509-19
9312010
J Cell Sci. 2006 Mar 15;119(Pt 6):979-87
16525119
J Cell Sci. 2006 May 15;119(Pt 10):2107-18
16638806
Annu Rev Biochem. 2013;82:357-85
23746258
Curr Biol. 2003 Apr 29;13(9):734-43
12725730
EMBO Rep. 2014 Feb;15(2):191-8
24375676
Nat Struct Mol Biol. 2004 Oct;11(10):984-91
15378033
Biol Open. 2013 Oct 16;2(11):1270-8
24244865
Traffic. 2012 Feb;13(2):218-33
21995724
Mol Biol Cell. 2009 Jan;20(1):410-8
18946085
Nat Rev Mol Cell Biol. 2010 Feb;11(2):103-12
20094051
Nat Cell Biol. 2000 Aug;2(8):531-9
10934474
FEBS Lett. 2008 Jan 23;582(2):190-6
18070602
J Cell Sci. 2009 Sep 1;122(Pt 17):3113-22
19654215
Nat Rev Mol Cell Biol. 2004 Mar;5(3):220-31
14991002
Nature. 2003 Feb 13;421(6924):753-6
12610628
Nat Commun. 2014 Sep 19;5:4980
25236484
Mol Biol Cell. 2008 May;19(5):2300-10
18305100
Nat Rev Cancer. 2011 Dec 15;12(1):23-38
22169974
Adv Exp Med Biol. 2009;656:30-40
19928350
Nat Rev Mol Cell Biol. 2014 Apr;15(4):225-42
24651541
Nat Immunol. 2015 Nov;16(11):1195-203
26390157